CSL Canada Announces First Canadian Patient Receives HEMGENIX® Hemophilia B Gene Therapy in Ontario, Canada
Canada and CSL Seqirus, a Global Leader in Influenza Vaccines, agree on new Pandemic Preparedness Contract
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® Over Five Years
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering
Recent RWE Data Show Cell-Based Influenza Vaccines Offer 20% Greater Protection in the Prevention of Test-Confirmed Influenza in Pediatric and Adult Populations Relative to Standard Egg-Based Influenza Vaccines
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance for Public Reimbursement of HEMGENIX® , the First Gene Therapy for Hemophilia B
CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
Brixton Metals Drills 906 g/t Silver over 4.3 m, including 1,329 g/t Silver over 1.8 m, all within 23.7 m of 206.6 g/t Silver at its Langis Project And 4.95 m of 493 g/t silver, including 1,798 g/t silver over 1.0 m
Charbone Annonce l'Ajout de 22 Nouveaux Clients d'Helium au Quebec et Poursuit l'Expansion de sa Plateforme de Gaz Industriels
CHARBONE Announces the Addition of 22 New Helium Customers in Quebec and Continues the Expansion of its Industrial Gas Platform
CoTec Announces Mid-project Update For Its Lac Jeannine Mine Tailings Reclamation And Restoration Project, Québec, Canada
Earthwise Minerals Intercepts Mineralization and Alteration in All Drill Holes at the Iron Range Gold Project, British Columbia
